Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313) Interactions
There are 343 drugs known to interact with Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313) (sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)). Of the total drug interactions, 1 is major, 339 are moderate, and 3 are minor.
- View all 343 medications that may interact with Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313)
Most frequently checked interactions
View interaction reports for Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313) (sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)) and the medicines listed below.
- acetaminophen / oxycodone
- acetazolamide
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Ajovy (fremanezumab)
- ashwaganda
- Benadryl (diphenhydramine)
- bupropion
- calcium / vitamin d
- Claritin Reditabs (loratadine)
- cranberry
- cyclobenzaprine
- diclofenac
- estradiol
- Estradiol Patch (estradiol)
- etodolac
- Flovent HFA (fluticasone)
- Flucelvax Quadrivalent (influenza virus vaccine, inactivated)
- Kaopectate Anti-Diarrheal Upset Stomach Reliever (bismuth subsalicylate)
- Klor-Con M10 (potassium chloride)
- L-Tyrosine (tyrosine)
- levothyroxine
- Lidoderm (lidocaine topical)
- liothyronine
- magnesium oxide
- methylphenidate
- Neurontin (gabapentin)
- Nodolor (acetaminophen / dichloralphenazone / isometheptene mucate)
- NuvaRing (ethinyl estradiol / etonogestrel)
- Omega 3-6-9 Complex (omega-3 polyunsaturated fatty acids)
- ondansetron
Report options
QR code containing a link to this page
More about Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313) (sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313))
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.